| Name | Title | Contact Details |
|---|
Diplomat is the nation`s largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. We build solutions for today`s issues while laying the groundwork for tomorrow`s healthcare. Rooted in specialty pharmacy, our brands harness innovation to create a healthier world. These include: • Diplomat Specialty Infusion Group: Our specialty infusion services deliver treatments nationwide, but a high-touch approach makes our care personal. • Diplomat Specialty Pharmacy: We help patients across the country face complex and often rare conditions. • CastiaRx: The industry`s leading specialty benefit manager, combining full-service pharmacy benefit manager capabilities with deep specialty expertise. • EnvoyHealth: Firewalled from other Diplomat business, EnvoyHealth is a full-service healthcare solutions company using innovation and technology to help partners improve lives. At Diplomat, we are more than 2,000 professionals working together nationwide to help patients realize health, happiness, and longer, fuller lives. We stand behind our employees with exceptional benefits, continuing education, and award-winning wellness programs. We want this to be the greatest place you`ve ever worked. And we believe it will be.
Why American Addiction Centers? We take a big picture approach to addiction recovery treatment – addressing the individual`s whole lifestyle in relation to substance use, alcohol and binge eating addiction and partnering with the family throughout the treatment process whenever possible. With our research-based programs, our inpatient treatment centers don`t just focus on the problem; we strengthen the individual and focus on the future. Whether it`s the initial clinical assessments, medically supervised detox, residential rehabilitation or aftercare, our team is present for and committed to each step of the recovery process for every individual. American Addiction Centers is an equal opportunity and drug free employer. All decisions regarding recruiting and hiring will be made without unlawful discrimination on the basis of race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, or age.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).
Sound Technology Inc is a State College, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Florida Cardiology, PA is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Winter Park, FL. To find more information about Florida Cardiology, PA, please visit www.flcard.com